Vaxart Schedules 2025 Financial Results and Stockholder Chat
Event summary
- Vaxart to host full-year 2025 financial results call on March 12, 2026, at 4:30 p.m. ET.
- Stockholder fireside chat scheduled for March 13, 2026, at 4:30 p.m. ET.
- Investors can submit questions in advance via email or webcast portal.
- Replays of both events will be available on Vaxart’s website post-event.
The big picture
Vaxart’s upcoming conference calls come at a critical juncture as the company seeks to validate its proprietary oral vaccine platform. The financial results will provide insight into its burn rate and funding runway, while the stockholder chat may reveal strategic shifts in response to competitive pressures in the vaccine market. The company’s ability to deliver on its pipeline could determine its long-term viability in a crowded biotech landscape.
What we're watching
- Financial Performance
- How Vaxart’s 2025 financial results will reflect progress in its oral vaccine development programs.
- Investor Sentiment
- Whether the stockholder fireside chat will address concerns over execution risks in clinical-stage biotech.
- Pipeline Updates
- The pace at which Vaxart advances its coronavirus, norovirus, influenza, and HPV vaccine candidates.
Related topics